{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:32:40Z","timestamp":1793395960592,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.cellsig.2026.112922","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:21:09Z","timestamp":1792106469000},"page":"112922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GSTM5 suppresses ovarian cancer progression in association with RASSF2A promoter hypomethylation and ferroptosis"],"prefix":"10.1016","volume":"150","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianMiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XinYu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoXue","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaNan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiangPing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112922_bb0005","article-title":"Advancements in ovarian cancer immunodiagnostics and therapeutics via phage display technology","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112922_bb0010","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.ccell.2024.08.016","article-title":"Ovarian cancer metastasis: looking beyond the surface","volume":"42","author":"Bayraktar","year":"2024","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.cellsig.2026.112922_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26104611","article-title":"Ovarian cancer-epidemiology, classification, pathogenesis, treatment, and estrogen receptors' molecular backgrounds","volume":"26","author":"Smolarz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112922_bb0020","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5634724","article-title":"Mitochondrial dysfunction pathway alterations offer potential biomarkers and therapeutic targets for ovarian cancer","volume":"2022","author":"Shen","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.cellsig.2026.112922_bb0025","article-title":"Mitochondria dysfunction-mediated molecular subtypes and gene prognostic index for prostate Cancer patients undergoing radical prostatectomy or radiotherapy","volume":"12","author":"Feng","year":"2022","journal-title":"Front. Oncol."},{"issue":"24","key":"10.1016\/j.cellsig.2026.112922_bb0030","doi-asserted-by":"crossref","first-page":"25294","DOI":"10.18632\/aging.104130","article-title":"Multiwalled carbon nanotubes inhibit cell migration and invasion by destroying actin cytoskeleton via mitochondrial dysfunction in ovarian cancer cells","volume":"12","author":"Zhang","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cellsig.2026.112922_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1275154","article-title":"The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.cellsig.2026.112922_bb0040","article-title":"Ferroptosis: mechanism, immunotherapy and role in ovarian cancer","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112922_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061505","article-title":"Ferroptosis and cancer: mitochondria meet the \"iron maiden\" cell death","volume":"9","author":"Battaglia","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112922_bb0050","doi-asserted-by":"crossref","first-page":"714","DOI":"10.14336\/AD.2023.0717","article-title":"Mitochondria-mediated Ferroptosis in diseases therapy: from molecular mechanisms to implications","volume":"15","author":"Feng","year":"2024","journal-title":"Aging Dis."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112922_bb0055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112922_bb0060","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.7150\/ijbs.83348","article-title":"The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112922_bb0065","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.21147\/j.issn.1000-9604.2025.06.13","article-title":"Curcumol overcomes cisplatin resistance and rewires glycolysis-H3K9la-ORC6 axis to trigger ferroptosis in bladder cancer","volume":"37","author":"Zhang","year":"2025","journal-title":"Chin. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112922_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3892\/ol.2020.11961","article-title":"Identification and verification of the prognostic value of the glutathione S-transferase mu genes in gastric cancer","volume":"20","author":"Chen","year":"2020","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112922_bb0075","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s12885-022-09711-0","article-title":"Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis","volume":"22","author":"Hao","year":"2022","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112922_bb0080","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.3233\/THC-231316","article-title":"Analysis of glutathione Stransferase mu class 5 gene methylation as a prognostic indicator in low-grade gliomas","volume":"32","author":"Wu","year":"2024","journal-title":"Technol. Health Care"},{"key":"10.1016\/j.cellsig.2026.112922_bb0085","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18157","article-title":"Identification of 10 differentially expressed genes involved in the tumorigenesis of cervical cancer via next-generation sequencing","volume":"12","author":"Xu","year":"2024","journal-title":"PeerJ"},{"issue":"19","key":"10.1016\/j.cellsig.2026.112922_bb0090","first-page":"8257","article-title":"A comprehensive understanding of ovarian carcinoma survival prognosis by novel biomarkers","volume":"23","author":"Wang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cellsig.2026.112922_bb0095","article-title":"Comprehensive analysis of the glutathione S-transferase mu (GSTM) gene family in ovarian cancer identifies prognostic and expression significance","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112922_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063056","article-title":"Anti-cancer effects and tumor marker role of glutathione S-transferase mu 5 in human bladder cancer","volume":"22","author":"Jou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112922_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13081872","article-title":"GSTM5 as a potential biomarker for treatment resistance in prostate cancer","volume":"13","author":"Porras-Quesada","year":"2025","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112922_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/biom13040688","article-title":"The multifaceted role of glutathione S-transferases in health and disease","volume":"13","author":"Mazari","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.cellsig.2026.112922_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/bs.vh.2022.09.002","article-title":"The antioxidant glutathione","volume":"121","author":"Averill-Bates","year":"2023","journal-title":"Vitam. Horm."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112922_bb0120","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00204-020-02838-8","article-title":"Glutaminases regulate glutathione and oxidative stress in cancer","volume":"94","author":"Mat\u00e9s","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cellsig.2026.112922_bb0125","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.copbio.2021.03.001","article-title":"Glutathione and its precursors in cancer","volume":"68","author":"Asantewaa","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112922_bb0130","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1186\/s12967-025-06840-5","article-title":"Unlocking the mitochondrial functional code: unraveling the pathogenesis of ovarian cancer and innovative targets to inhibit malignant behavior","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112922_bb0135","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellsig.2026.112922_bb0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.ircmb.2021.04.001","article-title":"Reactive oxygen species and DNA damage response in cancer","volume":"364","author":"Renaudin","year":"2021","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112922_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70947","article-title":"Reactive oxygen species: from tumorigenesis to therapeutic strategies in Cancer","volume":"14","author":"Attique","year":"2025","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112922_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cstres.2025.100108","article-title":"Reactive oxygen species in cancer: mechanistic insights and therapeutic innovations","volume":"30","author":"Ma","year":"2025","journal-title":"Cell Stress Chaperones"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112922_bb0155","article-title":"SLC40A1 in iron metabolism, ferroptosis, and disease: a review","volume":"16","author":"Zhang","year":"2024","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.cellsig.2026.112922_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217697","article-title":"Glutathione metabolism in ferroptosis and cancer therapy","volume":"621","author":"Xue","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2026.112922_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121110","article-title":"Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy","volume":"277","author":"Niu","year":"2021","journal-title":"Biomaterials"},{"issue":"15","key":"10.1016\/j.cellsig.2026.112922_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158423","article-title":"Glutathione-dependent pathways in cancer cells","volume":"25","author":"Kalinina","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112922_bb0175","article-title":"Paraptosis turning cellular stress into therapeutic weapon for urological diseases","volume":"9","author":"Wang","year":"2026","journal-title":"Research (Wash D C)."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112922_bb0180","first-page":"21","article-title":"Relationship between methylation status of RASSF2A gene promoter and endometriosis-associated ovarian cancer","volume":"32","author":"Xia","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112922_bb0185","first-page":"932","article-title":"Vincristine inhibits the proliferation of ovarian cancer cells by regulating the demethylation of RASSF2A","volume":"43","author":"Wang","year":"2021","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112922_bb0190","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1080\/15257770.2024.2356744","article-title":"Promoter methylation status of RASSF1A and RASSF2A tumor suppressor genes in endometrial endometrioid carcinomas","volume":"43","author":"Atmaca","year":"2024","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112922_bb0195","article-title":"Ten-eleven translocation family proteins: structure, biological functions, diseases, and targeted therapy","volume":"6","author":"Liang","year":"2025","journal-title":"MedComm (2020)."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112922_bb0200","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-immunol-080223-044610","article-title":"TET enzymes in the immune system: from DNA demethylation to immunotherapy, inflammation, and Cancer","volume":"42","author":"L\u00f3pez-Moyado","year":"2024","journal-title":"Annu. Rev. Immunol."},{"issue":"20","key":"10.1016\/j.cellsig.2026.112922_bb0205","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1111\/febs.70565","article-title":"Functional emergence driven by structural evolution of the DSBH domain in Fe(2+) and \u03b1-ketoglutarate-dependent family","volume":"293","author":"Yang","year":"2026","journal-title":"FEBS J."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826005814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:11:40Z","timestamp":1793394700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826005814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":41,"alternative-id":["S0898656826005814"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112922","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GSTM5 suppresses ovarian cancer progression in association with RASSF2A promoter hypomethylation and ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112922"}}